Lista de obras - Daniel I Feig - Dominio Público Uruguay

A causal role for uric acid in fructose-induced metabolic syndrome

artículo científico publicado en 2005

A sensitive and specific liquid chromatography-tandem mass spectrometry method for the determination of intracellular and extracellular uric acid.

artículo científico publicado en 2009

Added Sugars and Cardiovascular Disease Risk in Children: A Scientific Statement From the American Heart Association.

artículo científico publicado en 2016

Association between left ventricular mass index and cardiac function in pediatric dialysis patients.

artículo científico publicado en 2011

Calcium oxalate deposition in renal allografts: morphologic spectrum and clinical implications.

artículo científico publicado en 2004

Coincident activation of Th2 T cells with onset of the disease and differential expression of GRO-gamma in peripheral blood leukocytes in minimal change disease

artículo científico publicado en 2007

Cost-effectiveness of ambulatory blood pressure monitoring in the initial evaluation of hypertension in children

scientific article published on December 2008

Cytomegalovirus and Epstein-Barr virus infections among pediatric kidney transplant recipients at a center using universal Valganciclovir Prophylaxis

artículo científico publicado en 2019

Diuretic-induced hyperuricemia does not decrease cardiovascular risk.

artículo científico publicado en 2004

Does asymptomatic hyperuricaemia contribute to the development of renal and cardiovascular disease? An old controversy renewed.

artículo científico publicado en 2004

Frequent hemodialysis with NxStage system in pediatric patients receiving maintenance hemodialysis.

artículo científico publicado en 2007

Hyperuricemia and hypertension.

artículo científico publicado en 2012

Hyperuricemia in childhood primary hypertension.

artículo científico publicado en 2003

Inaccuracy in pediatric outpatient blood pressure measurement

artículo científico publicado en 2007

Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?

artículo científico publicado en 2003

Minimal change disease with IgM+ immunofluorescence: a subtype of nephrotic syndrome.

artículo científico publicado en 2009

Mutagenesis by metal-induced oxygen radicals

artículo científico publicado en 1994

Nephron number, uric acid, and renal microvascular disease in the pathogenesis of essential hypertension

artículo científico publicado en 2006

Obstructive sleep apnea and periodic limb movement disorder in a population of children with hypertension and/or nocturnal nondipping blood pressures.

artículo científico publicado en 2015

Oxygen radical induced mutagenesis is DNA polymerase specific.

artículo científico publicado en 1994

Pharmacokinetics, Pharmacodynamics, and Safety of Lisinopril in Pediatric Kidney Transplant Patients: Implications for Starting Dose Selection

artículo científico publicado en 2015

Phase I study of single-dose pharmacokinetics and pharmacodynamics of belatacept in adolescent kidney transplant recipients

artículo científico publicado en 2019

Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease.

artículo científico publicado en 2007

Prevalence of acute kidney injury during pediatric admissions for acute chest syndrome.

artículo científico publicado en 2016

Reactive oxygen species in tumorigenesis.

artículo científico publicado en 1994

Recent advances in the diagnosis and treatment of pheochromocytoma in children.

artículo científico publicado en 2007

Resurrection of uric acid as a causal risk factor in essential hypertension

scientific article published on 22 November 2004

Reverse chemical mutagenesis: identification of the mutagenic lesions resulting from reactive oxygen species-mediated damage to DNA.

artículo científico publicado en 1994

Safety and efficacy of intravenous labetalol for hypertensive crisis in infants and small children.

scientific article published on January 2011

Serum Uric Acid and Risk of CKD in Type 2 Diabetes

artículo científico publicado en 2015

Serum urate: a biomarker or treatment target in pediatric hypertension?

artículo científico publicado en 2013

Serum uric acid and the risk of hypertension and chronic kidney disease.

artículo científico publicado en 2014

Serum uric acid is associated with high blood pressure in pediatric hemodialysis patients

artículo científico publicado en 2011

Serum uric acid: a risk factor and a target for treatment?

artículo científico publicado en 2006

Severe anemia early in life as a risk factor for sickle-cell kidney disease.

artículo científico publicado en 2016

Smaller circuits for smaller patients: improving renal support therapy with Aquadex™.

artículo científico publicado en 2015

Sour notes on sweet drinks.

artículo científico publicado en 2009

Subtle renal injury is likely a common mechanism for salt-sensitive essential hypertension.

artículo científico publicado en 2005

Sugar-sweetened beverages and hypertension

artículo científico publicado en 2010

The effects of urate lowering therapy on inflammation, endothelial function, and blood pressure (SURPHER) study design and rationale

artículo científico publicado en 2016

The role of uric acid in pediatric hypertension.

artículo científico publicado en 2007

The role of uric acid in the pathogenesis of hypertension in the young.

artículo científico

The utility of cortical-sparing adrenalectomy in pheochromocytomas associated with genetic syndromes

artículo científico publicado en 2013

Uncontrolled hypertension in children on hemodialysis

scientific article published on 01 January 2010

Uric Acid and Hypertension ⬇️

artículo científico publicado el 1 de septiembre de 2011

Uric acid and cardiovascular risk

artículo científico publicado en 2008

Uric acid and hypertension

artículo científico publicado en 2006

Uric acid and hypertension: cause or effect?

scientific article published on April 2010

Uric acid reduction rectifies prehypertension in obese adolescents.

artículo científico publicado en 2012

Uric acid: a clinically useful marker to distinguish preeclampsia from gestational hypertension.

artículo científico publicado en 2011

Uric acid: a novel mediator and marker of risk in chronic kidney disease?

artículo científico publicado en 2009

What are the key arguments against uric acid as a true risk factor for hypertension?

artículo científico publicado en 2013

Lista de obras de Daniel I Feig

A causal role for uric acid in fructose-induced metabolic syndrome

A sensitive and specific liquid chromatography-tandem mass spectrometry method for the determination of intracellular and extracellular uric acid.

Added Sugars and Cardiovascular Disease Risk in Children: A Scientific Statement From the American Heart Association.

Association between left ventricular mass index and cardiac function in pediatric dialysis patients.

Calcium oxalate deposition in renal allografts: morphologic spectrum and clinical implications.

Coincident activation of Th2 T cells with onset of the disease and differential expression of GRO-gamma in peripheral blood leukocytes in minimal change disease

Cost-effectiveness of ambulatory blood pressure monitoring in the initial evaluation of hypertension in children

Cytomegalovirus and Epstein-Barr virus infections among pediatric kidney transplant recipients at a center using universal Valganciclovir Prophylaxis

Diuretic-induced hyperuricemia does not decrease cardiovascular risk.

Does asymptomatic hyperuricaemia contribute to the development of renal and cardiovascular disease? An old controversy renewed.

Frequent hemodialysis with NxStage system in pediatric patients receiving maintenance hemodialysis.

Hyperuricemia and hypertension.

Hyperuricemia in childhood primary hypertension.

Inaccuracy in pediatric outpatient blood pressure measurement

Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?

Minimal change disease with IgM+ immunofluorescence: a subtype of nephrotic syndrome.

Mutagenesis by metal-induced oxygen radicals

Nephron number, uric acid, and renal microvascular disease in the pathogenesis of essential hypertension

Obstructive sleep apnea and periodic limb movement disorder in a population of children with hypertension and/or nocturnal nondipping blood pressures.

Oxygen radical induced mutagenesis is DNA polymerase specific.

Pharmacokinetics, Pharmacodynamics, and Safety of Lisinopril in Pediatric Kidney Transplant Patients: Implications for Starting Dose Selection

Phase I study of single-dose pharmacokinetics and pharmacodynamics of belatacept in adolescent kidney transplant recipients

Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease.

Prevalence of acute kidney injury during pediatric admissions for acute chest syndrome.

Reactive oxygen species in tumorigenesis.

Recent advances in the diagnosis and treatment of pheochromocytoma in children.

Resurrection of uric acid as a causal risk factor in essential hypertension

Reverse chemical mutagenesis: identification of the mutagenic lesions resulting from reactive oxygen species-mediated damage to DNA.

Safety and efficacy of intravenous labetalol for hypertensive crisis in infants and small children.

Serum Uric Acid and Risk of CKD in Type 2 Diabetes

Serum urate: a biomarker or treatment target in pediatric hypertension?

Serum uric acid and the risk of hypertension and chronic kidney disease.

Serum uric acid is associated with high blood pressure in pediatric hemodialysis patients

Serum uric acid: a risk factor and a target for treatment?

Severe anemia early in life as a risk factor for sickle-cell kidney disease.

Smaller circuits for smaller patients: improving renal support therapy with Aquadex™.

Sour notes on sweet drinks.

Subtle renal injury is likely a common mechanism for salt-sensitive essential hypertension.

Sugar-sweetened beverages and hypertension

The effects of urate lowering therapy on inflammation, endothelial function, and blood pressure (SURPHER) study design and rationale

The role of uric acid in pediatric hypertension.

The role of uric acid in the pathogenesis of hypertension in the young.

The utility of cortical-sparing adrenalectomy in pheochromocytomas associated with genetic syndromes

Uncontrolled hypertension in children on hemodialysis

Uric Acid and Hypertension ⬇️

Uric acid and cardiovascular risk

Uric acid and hypertension

Uric acid and hypertension: cause or effect?

Uric acid reduction rectifies prehypertension in obese adolescents.

Uric acid: a clinically useful marker to distinguish preeclampsia from gestational hypertension.

Uric acid: a novel mediator and marker of risk in chronic kidney disease?

What are the key arguments against uric acid as a true risk factor for hypertension?